125 related articles for article (PubMed ID: 25778339)
1. Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab.
Ates O; Sunar V; Babacan T; Akin S; Kertmen N; Altundag K
J BUON; 2015; 20(1):349. PubMed ID: 25778339
[No Abstract] [Full Text] [Related]
2. Acquired angioedema and marginal zone lymphoma.
Lam DH; Levy NB; Nickerson JM; Gruenberg DA; Lansigan F
J Clin Oncol; 2012 Jun; 30(16):e151-3. PubMed ID: 22508826
[No Abstract] [Full Text] [Related]
3. Acquired angioedema responding to rituximab.
Hassan A; Amarger S; Tridon A; Ponard D; Souteyrand P; D'Incan M
Acta Derm Venereol; 2011 Oct; 91(6):733-4. PubMed ID: 21691703
[No Abstract] [Full Text] [Related]
4. Atypical presentation of acquired angioedema.
Baird D; Craig TJ; Miller JJ
Cutis; 2018 Feb; 101(2):E14-E16. PubMed ID: 29554170
[No Abstract] [Full Text] [Related]
5. Syndrome of inappropriate antidiuretic hormone secretion due to marginal zone lymphoma: responding to rituximab.
Bockorny B; Dasanu CA
Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):220-2. PubMed ID: 22578816
[No Abstract] [Full Text] [Related]
6. Mucosa-associated lymphoid tissue (MALT) lymphoma presenting as subglottic stenosis: single-agent treatment using rituximab.
Bielinski C; Luu HS; Mau T
Otolaryngol Head Neck Surg; 2014 Feb; 150(2):334-5. PubMed ID: 24334958
[No Abstract] [Full Text] [Related]
7. Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma.
Biondo F; Matturro A; Santoro C; Leporace A; D'Elia G; Baldacci E; Pignoloni P; Pulsoni A; Foà R; Mazzucconi M
Haemophilia; 2012 Jan; 18(1):e34-5. PubMed ID: 22059776
[No Abstract] [Full Text] [Related]
8. Lymphoma-associated paraneoplastic angioedema with normal C1-inhibitor activity: does danazol work?
Gaur S; Cooley J; Aish L; Weinstein R
Am J Hematol; 2004 Nov; 77(3):296-8. PubMed ID: 15495244
[TBL] [Abstract][Full Text] [Related]
9. Intralesional rituximab for primary iris lymphoma.
Demirci H; Grant JS; Elner VM
JAMA Ophthalmol; 2015 Jan; 133(1):104-5. PubMed ID: 25211092
[No Abstract] [Full Text] [Related]
10. Successful rituximab B lymphocyte depletion therapy for angioedema due to acquired C1 inhibitor protein deficiency: association with reduced C1 inhibitor protein autoantibody titers.
Dreyfus DH; Na CR; Randolph CC; Kearney D; Price C; Podell D
Isr Med Assoc J; 2014 May; 16(5):315-6. PubMed ID: 24979840
[No Abstract] [Full Text] [Related]
11. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T cell-mediated gastritis after rituximab treatment for gastric malt lymphoma.
Stalika E; Kanellis G; Papalexandri A; Iskas M; Vrakidou E; Demonakou M; Anagnostopoulos A; Stamatopoulos K; Papadaki T
Leuk Lymphoma; 2014 Mar; 55(3):702-5. PubMed ID: 23725385
[No Abstract] [Full Text] [Related]
13. Recurrence of IgG4-related disease following treatment with rituximab.
Murakami J; Matsui S; Ishizawa S; Arita K; Wada A; Miyazono T; Hounoki H; Shinoda K; Taki H; Sugiyama T
Mod Rheumatol; 2013 Nov; 23(6):1226-30. PubMed ID: 22956241
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune phenomena in untreated and treated marginal zone lymphoma.
Grabska J; Dasanu CA
Expert Opin Pharmacother; 2011 Oct; 12(15):2369-79. PubMed ID: 21679092
[TBL] [Abstract][Full Text] [Related]
15. Acquired C1-esterase inhibitor deficiency and positive lupus anticoagulant accompanied by splenic marginal zone B-cell lymphoma.
Sugisaki K; Itoh K; Tamaru J
Clin Exp Rheumatol; 2007; 25(4):627-9. PubMed ID: 17888223
[TBL] [Abstract][Full Text] [Related]
16. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
Else M; Marín-Niebla A; de la Cruz F; Batty P; Ríos E; Dearden CE; Catovsky D; Matutes E
Br J Haematol; 2012 Nov; 159(3):322-8. PubMed ID: 23016878
[TBL] [Abstract][Full Text] [Related]
17. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.
Seker M; Bilici A; Ustaalioglu BO; Salman T; Sonmez B; Canpolat NA; Salepci T; Gumus M; Yaylaci M
Leuk Res; 2009 Sep; 33(9):e154-6. PubMed ID: 19386361
[No Abstract] [Full Text] [Related]
18. Case report: Colonic MALT lymphoma.
Khan M; Chon D; Patil A
J Gastrointest Cancer; 2012 Dec; 43(4):622-5. PubMed ID: 22965352
[No Abstract] [Full Text] [Related]
19. A review of uncommon swelling provides useful reminders.
Mandell BF
Cleve Clin J Med; 2013 May; 80(5):261. PubMed ID: 23636918
[No Abstract] [Full Text] [Related]
20. Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma.
Carter SJ; Bernstein SH; Friedberg JW; Barr PM
Leuk Res; 2011 Nov; 35(11):e223-4. PubMed ID: 21824654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
